Lv0
0 积分 2024-07-30 加入
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
1个月前
已完结
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
1个月前
已完结
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
1个月前
已完结
Do it faster with PICOS: Generative AI-Assisted systematic review screening
1个月前
已完结
Efficacy and safety of GLP ‐1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta‐analysis
1个月前
已完结
Meta‐analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis ( MASH )
3个月前
已完结
Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials
3个月前
已完结
Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Observational Evidence in Geriatric Patients AGING-HF
3个月前
已完结
Lifestyle factors and metabolomic aging biomarkers: Meta-analysis of cross-sectional and longitudinal associations in three prospective cohorts
4个月前
已完结
Which is the Most Reasonable Anti-aging Strategy: Meta-analysis
8个月前
已完结
皖公网安备34019202002308
